The Johns Hopkins Post-Acute COVID-19 Team (JH PACT) Program is a collaboration between the Division of Pulmonary & Critical Care Medicine and the Department of Physical Medicine and Rehabilitation. Our goal is to provide interdisciplinary, standardized care to address the unique needs of COVID-19 survivors.
JH PACT consists of two core service lines that work in tandem to provide comprehensive care. As needed, our physicians may refer patients to other specialists to support recovery.
Our pulmonary and rehabilitation physicians conduct appointments via telemedicine or on campus.
Our rehabilitation therapy services include physical, occupational, speech-language therapy and neuropsychology.
Severely ill patients commonly experience impairments in physical function, mental health and cognition, which is collectively termed “post-hospital syndrome,” or “post-intensive care syndrome” (PICS) in the case of ICU survivors. Further, there are a growing number of COVID-19 survivors who were not hospitalized but have persistent symptoms, including shortness of breath, fatigue, headaches, palpitations and impairments in mental health and cognition. We recognize the need for a team approach to support the extraordinary number of COVID-19 survivors while driving care forward with comprehensive and standardized assessments, evidence-based approaches and the very best in patient-centered care.
In some people who recover from COVID-19, lingering health problems that can last for months. Hear from PACT team members and two "long hauler" patients as they describe their experience.
Provider referrals are required for JH PACT clinic appointments. Learn more about referral criteria.
Summary: The goal of the COVID Patient Registry is to collect data on individuals who were diagnosed with COVID-19 and who are seen for follow up care at Johns Hopkins. We hope to understand the natural history of the illness and ultimately improve the care and survival of those who were treated for COVID-19 to improve understanding, treatment and survival.
P.I.: Ann Parker, M.D., Ph.D. Contact: [email protected]
Summary: People with solid organ transplants are at high risk of developing COVID-19, but the long-term neurocognitive aspects of COVID-19 infection (such as anosmia, loss of taste, loss of hearing, headaches, mental “fogginess,” confusion and fatigue) in this population is still not fully understood.
This study aims to: 1) Estimate the prevalence of mental, cognitive and physical impairments in solid organ transplant patients hospitalized with COVID-19 in the short-term and long-term period; and 2) understand changes in mental, cognitive and physical impairment in solid organ transplant patients hospitalized with COVID-19 in the long-term.
P.I.: Sami Alasfar, M.B.B.S., M.D. Contact: [email protected]
Summary: No studies of post-acute COVID-19 symptoms and sequelae have focused specifically on people living with HIV (PWH). Given elevated baseline levels of inflammation and T-cell activation in this population, we hypothesize that PWH are more likely to experience persistent symptoms after acute COVID-19 than HIV negative people.
This is part of a national study conducted remotely with telephone and online surveys and blood samples collected via a mobile phlebotomy company at the participant’s home. Specifically, this study aims to: 1) formally and prospectively characterize symptoms and sequelae of post-acute COVID-19 in PWH as compared to HIV-negative COVID-19 survivors and PWH and HIV-negative people with no history of COVID-19; and 2) identify blood-based biomarkers or immune signature(s) that associate with prolonged or persistent post-acute COVID-19 symptoms in PWH in comparison with the general population.
P.I.: Annie Antar, M.D., Ph.D. Contact: [email protected]